tiprankstipranks
Trending News
More News >
PremiumCompany AnnouncementsCG Oncology Announces Promising Phase 3 Trial Results
11d ago
Premium
Ratings
Promising Potential of CG Oncology’s Cretostimogene: A Buy Rating Justified by Superior Performance and Safety Profile
11d ago
Premium
Ratings
Buy Rating for CG Oncology, Inc. Driven by Promising Therapeutic Developments and Strong Safety Profile of Creto
11d ago
CG Oncology initiated with a Sector Perform at Scotiabank
PremiumThe FlyCG Oncology initiated with a Sector Perform at Scotiabank
23d ago
Premium
Ratings
Buy Rating Affirmed for CG Oncology Amid Promising Trial Data and Market Opportunities
1M ago
Premium
Ratings
Buy Rating for CG Oncology, Inc. Driven by Promising Developments in Bladder Cancer Treatment
1M ago
PremiumRatingsPromising Phase 3 Trial Results and Strong Market Potential Drive Buy Rating for CG Oncology
2M ago
Premium
Ratings
Buy Rating for CG Oncology: Promising Phase 3 Results and Strong Safety Profile of Cretostimogene
2M ago
Premium
Ratings
Buy Rating for CG Oncology Backed by Promising Phase 3 Study Results and Strong Safety Profile
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100